Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study.
about
P2860
Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Switching from infliximab inno ...... onal prospective cohort study.
@en
Switching from infliximab inno ...... onal prospective cohort study.
@nl
type
label
Switching from infliximab inno ...... onal prospective cohort study.
@en
Switching from infliximab inno ...... onal prospective cohort study.
@nl
prefLabel
Switching from infliximab inno ...... onal prospective cohort study.
@en
Switching from infliximab inno ...... onal prospective cohort study.
@nl
P2093
P2860
P356
P1476
Switching from infliximab inno ...... ional prospective cohort study
@en
P2093
D C van Renswouw
E M H Schmitz
J W A Straathof
M A C Broeren
M E C van de Poll
P J Boekema
V Scharnhorst
P2860
P304
P356
10.1111/APT.14453
P407
P577
2017-12-05T00:00:00Z